RxDoctor Payments Data

Shiny Thomas, NP

Adult Medicine · Mesa, AZNPI 1558916247

Payments from drug & device makers

What this record shows

13 manufacturers reported payments, led by Medtronic at 58.0% of the total. 2025 is the largest year on record at $1,599, 3.6 times the $441 reported in 2021. Among adult medicine clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,862in general payments, 2019–2025

Across 108 payments — averaging $35.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Boston Scientific$747
  • Novartis$278
  • Bard Peripheral Vascular, Inc.$199
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$162
  • Inspire Medical Systems, Inc.$54
  • plus $182 from 7 others

What the payments were for

  • Travel & lodging$1,85848%
  • Food & beverage$2,00452%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,862 in reported general payments places this provider in the 90th percentile of 35 adult medicine providers in Arizona.

See all adult medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$86,215
Medicare patients
253
Services billed
653

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban74$106,537
EntrestoSacubitril/Valsartan42$48,203
JardianceEmpagliflozin16$29,451
XareltoRivaroxaban13$22,719
Amiodarone Hcl77$1,985
Losartan Potassium83$1,073
Atorvastatin Calcium73$775
Metoprolol Succinate67$635
Ezetimibe16$522
ClopidogrelClopidogrel Bisulfate48$446
Lisinopril60$391
Carvedilol37$369
Amlodipine Besylate43$351
SotalolSotalol Hcl13$347
Metoprolol Tartrate70$331

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$278$48,20342 claims
Johnson & JohnsonXarelto$12$22,71913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 35 adult medicine providers in Arizona.

Other adult medicine in Mesa

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →